Oxidative and nitrosative stress in the metastatic microenvironment

Cancers

Volumn 2, Issue 2, 2010, Pages 274-304

  Ortega, Ángel L ^a   Mena, Salvador ^b   Estrela, José M ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b Green Molecular SL   (Spain)

Author keywords

Metastases; Reactive nitrogen species; Reactive oxygen species; Tumor microenvironment

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; CURCUMIN; CYTOKINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; EPIGALLOCATECHIN GALLATE; FATTY ACID; GROWTH FACTOR; GUANINE; HYDROGEN PEROXIDE; LIPID; N(G) NITROARGININE; NITRIC OXIDE; PTEROSTILBENE; QUERCETIN; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; RESVERATROL; STILBENE DERIVATIVE; THYMINE; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; CANCER CELL; CAPILLARY ENDOTHELIUM; CELL ADHESION; CELL FUNCTION; CELL HETEROGENEITY; CELL INTERACTION; CELL SUBPOPULATION; CELL SURVIVAL; CYTOTOXICITY; DNA CROSS LINKING; ENDOTHELIUM CELL; ENZYME ACTIVATION; FATTY ACID DESATURATION; GENOMIC INSTABILITY; HUMAN; IMMUNOCOMPETENT CELL; LIPID OXIDATION; MACROPHAGE; METASTASIS POTENTIAL; NITROSATIVE STRESS; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PHENOTYPE; POINT MUTATION; PROTEIN CROSS LINKING; PROTEIN PROCESSING; REVIEW; SISTER CHROMATID EXCHANGE; TUMOR CELL; TUMOR MICROENVIRONMENT; TUMOR SEEDING; TUMOR VASCULARIZATION; VASCULAR ENDOTHELIUM;

EID: 79952272390     PISSN: None     EISSN: 20726694     Source Type: Journal    
DOI: 10.3390/cancers2020274     Document Type: Review

References (219)

1. Hanahan, D.; Weinberg, R.A. The hallmarks of cancer. Cell 2000, 100, 57-70.
2. Steeg, P.S. Tumor metastasis: mechanistic insights and clinical challenges. Nat. Med. 2006, 12, 895-904.
3. Oberley, T.D. Oxidative damage and cancer. Am. J. Pathol. 2002, 160, 403-408.
4. Espey, M.G.; Miranda, K.M.; Thomas, D.D.; Xavier, S.; Citrin, D.; Vitek, M.P.; Wink, D.A. A chemical perspective on the interplay between NO, reactive oxygen species, and reactive nitrogen oxide species. Ann. N. Y. Acad. Sci. 2002, 962, 195-206.
5. Li, H.; Poulos, T.L. Structure-function studies on nitric oxide synthases. J. Inorg. Biochem. 2005, 99, 293-305.
6. Lundberg, J.O.; Weitzberg, E. NO generation from nitrite and its role in vascular control. Arterioscler. Thromb. Vasc. Biol. 2005, 25, 915-922.
7. Gutteridge, J.M.; Halliwell, B. Free radicals and antioxidants in the year 2000. A historical look to the future. Ann. N. Y. Acad. Sci. 2000, 899, 136-147.
8. Allen, R.G.; Tresini, M. Oxidative stress and gene regulation. Free Radic. Biol. Med. 2000, 28, 463-499.
9. Kamata, H.; Hirata, H. Redox regulation of cellular signalling. Cell Signal 1999, 11, 1-14.
10. Cerutti, P.; Shah, G.; Peskin, A.; Amstad, P. Oxidant carcinogenesis and antioxidant defense. Ann. N. Y. Acad. Sci. 1992, 663, 158-166.
11. Dhalla, N.S.; Temsah, R.M.; Netticadan, T. Role of oxidative stress in cardiovascular diseases. J. Hypertens. 2000, 18, 655-673.
12. Sayre, L.M.; Smith, M.A.; Perry, G. Chemistry and biochemistry of oxidative stress in neurodegenerative disease. Curr. Med. Chem. 2001, 8, 721-738.
13. Jenner, P. Oxidative stress in Parkinson's disease. Ann. Neurol. 2003, 53 Suppl. 3, S26-36; discussion S36-28.
14. Dalle-Donne, I.; Rossi, R.; Colombo, R.; Giustarini, D.; Milzani, A. Biomarkers of oxidative damage in human disease. Clin. Chem. 2006, 52, 601-623.
15. Valko, M.; Leibfritz, D.; Moncol, J.; Cronin, M.T.; Mazur, M.; Telser, J. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 2007, 39, 44-84.
16. Lacal, J.C.; Srivastava, S.K.; Anderson, P.S.; Aaronson, S.A. Ras p21 proteins with high or low GTPase activity can efficiently transform NIH/3T3 cells. Cell 1986, 44, 609-617.
17. Westra, W.H.; Slebos, R.J.; Offerhaus, G.J.; Goodman, S.N.; Evers, S.G.; Kensler, T.W.; Askin, F.B.; Rodenhuis, S.; Hruban, R.H. K-ras oncogene activation in lung adenocarcinomas from former smokers. Evidence that K-ras mutations are an early and irreversible event in the development of adenocarcinoma of the lung. Cancer 1993, 72, 432-438.
18. Belinsky, S.A. Role of the cytosine DNA-methyltransferase and p16INK4a genes in the development of mouse lung tumors. Exp. Lung Res. 1998, 24, 463-479.
19. Bennett, W.P.; Colby, T.V.; Travis, W.D.; Borkowski, A.; Jones, R.T.; Lane, D.P.; Metcalf, R.A.; Samet, J.M.; Takeshima, Y.; Gu, J.R., et al. p53 protein accumulates frequently in early bronchial neoplasia. Cancer Res. 1993, 53, 4817-4822.
20. Chung, F.L.; Xu, Y. Increased 8-oxodeoxyguanosine levels in lung DNA of A/J mice and F344 rats treated with the tobacco-specific nitrosamine 4-(methylnitrosamine)-1-(3-pyridyl)-1-butanone. Carcinogenesis 1992, 13, 1269-1272.
21. Szabo, E.; Riffe, M.E.; Steinberg, S.M.; Birrer, M.J.; Linnoila, R.I. Altered cJUN expression: an early event in human lung carcinogenesis. Cancer Res. 1996, 56, 305-315.
22. Volm, M.; van Kaick, G.; Mattern, J. Analysis of c-fos, c-jun, c-erbB1, c-erbB2 and c-myc in primary lung carcinomas and their lymph node metastases. Clin. Exp. Metastasis 1994, 12, 329-334.
23. Marnett, L.J. Oxyradicals and DNA damage. Carcinogenesis 2000, 21, 361-370.
24. Wiseman, H.; Halliwell, B. Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem. J. 1996, 313(Pt 1), 17-29.
25. Ananthaswamy, H.N.; Price, J.E.; Goldberg, L.H.; Bales, E.S. Detection and identification of activated oncogenes in human skin cancers occurring on sun-exposed body sites. Cancer Res. 1988, 48, 3341-3346.
26. Sander, C.S.; Chang, H.; Hamm, F.; Elsner, P.; Thiele, J.J. Role of oxidative stress and the antioxidant network in cutaneous carcinogenesis. Int. J. Dermatol. 2004, 43, 326-335.
27. Jakobisiak, M.; Lasek, W.; Golab, J. Natural mechanisms protecting against cancer. Immunol. Lett. 2003, 90, 103-122.
28. Ohshima, H. Genetic and epigenetic damage induced by reactive nitrogen species: implications in carcinogenesis. Toxicol. Lett. 2003, 140-141, 99-104.
29. Hussain, S.P.; Hofseth, L.J.; Harris, C.C. Radical causes of cancer. Nat. Rev. Cancer 2003, 3, 276-285.
30. Toyokuni, S. Novel aspects of oxidative stress-associated carcinogenesis. Antioxid. Redox Signal 2006, 8, 1373-1377.
31. Halliwell, B. Oxidative stress and cancer: have we moved forward? Biochem. J. 2007, 401, 1-11.
32. Tsuzuki, T.; Egashira, A.; Igarashi, H.; Iwakuma, T.; Nakatsuru, Y.; Tominaga, Y.; Kawate, H.; Nakao, K.; Nakamura, K.; Ide, F.; Kura, S.; Nakabeppu, Y.; Katsuki, M.; Ishikawa, T.; Sekiguchi, M. Spontaneous tumorigenesis in mice defective in the MTH1 gene encoding 8-oxo-dGTPase. Proc. Natl. Acad. Sci. USA 2001, 98, 11456-11461.
33. De Bont, R.; van Larebeke, N. Endogenous DNA damage in humans: a review of quantitative data. Mutagenesis 2004, 19, 169-185.
34. Wang, D.; Kreutzer, D.A.; Essigmann, J.M. Mutagenicity and repair of oxidative DNA damage: insights from studies using defined lesions. Mutat. Res. 1998, 400, 99-115.
35. Stamler, J.S.; Singel, D.J.; Loscalzo, J. Biochemistry of nitric oxide and its redox-activated forms. Science 1992, 258, 1898-1902.
36. Lim, K.H.; Ancrile, B.B.; Kashatus, D.F.; Counter, C.M. Tumour maintenance is mediated by eNOS. Nature 2008, 452, 646-649.
37. Goetz, M.E.; Luch, A. Reactive species: a cell damaging rout assisting to chemical carcinogens. Cancer Lett. 2008, 266, 73-83.
38. Yin, H.; Porter, N.A. New insights regarding the autoxidation of polyunsaturated fatty acids. Antioxid. Redox Signal 2005, 7, 170-184.
39. Irani, K.; Xia, Y.; Zweier, J.L.; Sollott, S.J.; Der, C.J.; Fearon, E.R.; Sundaresan, M.; Finkel, T.; Goldschmidt-Clermont, P.J. Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science 1997, 275, 1649-1652.
40. Polytarchou, C.; Hatziapostolou, M.; Papadimitriou, E. Hydrogen peroxide stimulates proliferation and migration of human prostate cancer cells through activation of activator protein-1 and up-regulation of the heparin affin regulatory peptide gene. J. Biol. Chem. 2005, 280, 40428-40435.
41. Okada, H.; Mak, T.W. Pathways of apoptotic and non-apoptotic death in tumour cells. Nat. Rev. Cancer 2004, 4, 592-603.
42. Payne, S.L.; Fogelgren, B.; Hess, A.R.; Seftor, E.A.; Wiley, E.L.; Fong, S.F.; Csiszar, K.; Hendrix, M.J.; Kirschmann, D.A. Lysyl oxidase regulates breast cancer cell migration and adhesion through a hydrogen peroxide-mediated mechanism. Cancer Res. 2005, 65, 11429-11436.
43. Marshall, H.E.; Merchant, K.; Stamler, J.S. Nitrosation and oxidation in the regulation of gene expression. FASEB J. 2000, 14, 1889-1900.
44. Pelicano, H.; Carney, D.; Huang, P. ROS stress in cancer cells and therapeutic implications. Drug Resist. Updat. 2004, 7, 97-110.
45. Trachootham, D.; Zhou, Y.; Zhang, H.; Demizu, Y.; Chen, Z.; Pelicano, H.; Chiao, P.J.; Achanta, G.; Arlinghaus, R.B.; Liu, J.; Huang, P. Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate. Cancer Cell 2006, 10, 241-252.
46. Wink, D.A.; Vodovotz, Y.; Laval, J.; Laval, F.; Dewhirst, M.W.; Mitchell, J.B. The multifaceted roles of nitric oxide in cancer. Carcinogenesis 1998, 19, 711-721.
47. Oliva, M.R.; Iradi, A.; Garrido, F.; Ramos, M.; Oltra, A.M.; Muniz, P.; Saez, G.T. Oxidative stress induces the expression of the major histocompatibility complex in murine tumor cells. Free Radic. Res. 2001, 35, 119-128.
48. Estrela, J.M.; Carretero, J.; Ortega, A. Glutathione, sulfur amino acids and cancer. In Glutathione and Sulfur Amino Acids in Human Health and Disease; John Wiley & Sons: New York, NY, USA, 2009.
49. Nguyen, D.X.; Bos, P.D.; Massague, J. Metastasis: from dissemination to organ-specific colonization. Nat. Rev. Cancer 2009, 9, 274-284.
50. Minna, J.D.; Kurie, J.M.; Jacks, T. A big step in the study of small cell lung cancer. Cancer Cell 2003, 4, 163-166.
51. Husemann, Y.; Geigl, J.B.; Schubert, F.; Musiani, P.; Meyer, M.; Burghart, E.; Forni, G.; Eils, R.; Fehm, T.; Riethmuller, G.; Klein, C.A. Systemic spread is an early step in breast cancer. Cancer Cell 2008, 13, 58-68.
52. Paget, S. The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Rev. 1989, 8, 98-101.
53. Psaila, B.; Lyden, D. The metastatic niche: adapting the foreign soil. Nat. Rev. Cancer 2009, 9, 285-293.
54. Cameron, M.D.; Schmidt, E.E.; Kerkvliet, N.; Nadkarni, K.V.; Morris, V.L.; Groom, A.C.; Chambers, A.F.; MacDonald, I.C. Temporal progression of metastasis in lung: cell survival, dormancy, and location dependence of metastatic inefficiency. Cancer Res. 2000, 60, 2541-2546.
55. Goodison, S.; Kawai, K.; Hihara, J.; Jiang, P.; Yang, M.; Urquidi, V.; Hoffman, R.M.; Tarin, D. Prolonged dormancy and site-specific growth potential of cancer cells spontaneously disseminated from nonmetastatic breast tumors as revealed by labeling with green fluorescent protein. Clin. Cancer Res. 2003, 9, 3808-3814.
56. Brackstone, M.; Townson, J.L.; Chambers, A.F. Tumour dormancy in breast cancer: an update. Breast Cancer Res. 2007, 9, 208.
57. Aguirre-Ghiso, J.A. Models, mechanisms and clinical evidence for cancer dormancy. Nat. Rev. Cancer 2007, 7, 834-846.
58. Joyce, J.A.; Pollard, J.W. Microenvironmental regulation of metastasis. Nat. Rev. Cancer 2009, 9, 239-252.
59. Ridnour, L.A.; Thomas, D.D.; Switzer, C.; Flores-Santana, W.; Isenberg, J.S.; Ambs, S.; Roberts, D.D.; Wink, D.A. Molecular mechanisms for discrete nitric oxide levels in cancer. Nitric Oxide 2008, 19, 73-76.
60. Schumacker, P.T. Reactive oxygen species in cancer cells: live by the sword, die by the sword. Cancer Cell 2006, 10, 175-176.
61. Balkwill, F.; Mantovani, A. Inflammation and cancer: back to Virchow? Lancet 2001, 357, 539-545.
62. Hussain, S.P.; Harris, C.C. Inflammation and cancer: an ancient link with novel potentials. Int. J. Cancer 2007, 121, 2373-2380.
63. Moncada, S. Nitric oxide in the vasculature: physiology and pathophysiology. Ann. N Y. Acad. Sci. 1997, 811, 60-67; discussion 67-69.
64. Murata, J.; Tada, M.; Iggo, R.D.; Sawamura, Y.; Shinohe, Y.; Abe, H. Nitric oxide as a carcinogen: analysis by yeast functional assay of inactivating p53 mutations induced by nitric oxide. Mutat. Res. 1997, 379, 211-218.
65. Lala, P.K.; Chakraborty, C. Role of nitric oxide in carcinogenesis and tumour progression. Lancet Oncol. 2001, 2, 149-156.
66. Grimm, E.A.; Ellerhorst, J.; Tang, C.H.; Ekmekcioglu, S. Constitutive intracellular production of iNOS and NO in human melanoma: possible role in regulation of growth and resistance to apoptosis. Nitric Oxide 2008, 19, 133-137.
67. Kundu, J.K.; Surh, Y.J. Inflammation: gearing the journey to cancer. Mutat. Res. 2008, 659, 15-30.
68. Liu, Y.; Gao, W.; Zhang, D. Effects of cigarette smoke extract on A549 cells and human lung fibroblasts treated with transforming growth factor-beta1 in a coculture system. Clin. Exp. Med. 2009, doi: 10.1007/s10238-009-0081-x.
69. Halliday, G.M. Inflammation, gene mutation and photoimmunosuppression in response to UVR-induced oxidative damage contributes to photocarcinogenesis. Mutat. Res. 2005, 571, 107-120.
70. Rajalingam, K.; Schreck, R.; Rapp, U.R.; Albert, S. Ras oncogenes and their downstream targets. Biochim. Biophys. Acta 2007, 1773, 1177-1195.
71. Strano, S.; Dell'Orso, S.; Di Agostino, S.; Fontemaggi, G.; Sacchi, A.; Blandino, G. Mutant p53: an oncogenic transcription factor. Oncogene 2007, 26, 2212-2219.
72. Nishigori, C.; Hattori, Y.; Toyokuni, S. Role of reactive oxygen species in skin carcinogenesis. Antioxid. Redox Signal 2004, 6, 561-570.
73. Ortega, A.; Carretero, J.; Obrador, E.; Estrela, J.M. Tumoricidal activity of endothelium-derived NO and the survival of metastatic cells with high GSH and Bcl-2 levels. Nitric Oxide 2008, 19, 107-114.
74. Thiery, J.P. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2002, 2, 442-454.
75. Frame, M.C. Src in cancer: deregulation and consequences for cell behaviour. Biochim. Biophys. Acta 2002, 1602, 114-130.
76. 2-induced phosphorylation of ERK1/2 and PKB requires tyrosine kinase activity of insulin receptor and c-Src. Antioxid. Redox Signal 2005, 7, 1014-1020.
77. Sato, H.; Sato, M.; Kanai, H.; Uchiyama, T.; Iso, T.; Ohyama, Y.; Sakamoto, H.; Tamura, J.; Nagai, R.; Kurabayashi, M. Mitochondrial reactive oxygen species and c-Src play a critical role in hypoxic response in vascular smooth muscle cells. Cardiovasc. Res. 2005, 67, 714-722.
78. Saito, S.; Frank, G.D.; Mifune, M.; Ohba, M.; Utsunomiya, H.; Motley, E.D.; Inagami, T.; Eguchi, S. Ligand-independent trans-activation of the platelet-derived growth factor receptor by reactive oxygen species requires protein kinase C-delta and c-Src. J. Biol. Chem. 2002, 277, 44695-44700.
79. Basuroy, S.; Sheth, P.; Kuppuswamy, D.; Balasubramanian, S.; Ray, R.M.; Rao, R.K. Expression of kinase-inactive c-Src delays oxidative stress-induced disassembly and accelerates calcium-mediated reassembly of tight junctions in the Caco-2 cell monolayer. J. Biol. Chem. 2003, 278, 11916-11924.
80. Thomas, S.M.; Brugge, J.S. Cellular functions regulated by Src family kinases. Annu. Rev. Cell Dev. Biol. 1997, 13, 513-609.
81. Ma, Y.C.; Huang, X.Y. Novel regulation and function of Src tyrosine kinase. Cell Mol. Life Sci. 2002, 59, 456-462.
82. Kemble, D.J.; Sun, G. Direct and specific inactivation of protein tyrosine kinases in the Src and FGFR families by reversible cysteine oxidation. Proc. Natl. Acad. Sci. USA 2009, 106, 5070-5075.
83. Oo, M.L.; Senga, T.; Thant, A.A.; Amin, A.R.; Huang, P.; Mon, N.N.; Hamaguchi, M. Cysteine residues in the C-terminal lobe of Src: their role in the suppression of the Src kinase. Oncogene 2003, 22, 1411-1417.
84. Senga, T.; Hasegawa, H.; Tanaka, M.; Rahman, M.A.; Ito, S.; Hamaguchi, M. The cysteine-cluster motif of c-Src:its role for the heavy metal-mediated activation of kinase. Cancer Sci. 2008, 99, 571-575.
85. Rahman, M.A.; Senga, T.; Oo, M.L.; Hasegawa, H.; Biswas, M.H.; Mon, N.N.; Huang, P.; Ito, S.; Yamamoto, T.; Hamaguchi, M. The cysteine-cluster motif of c-Yes, Lyn and FAK as a suppressive module for the kinases. Oncol. Rep. 2008, 19, 975-980.
86. Giannoni, E.; Buricchi, F.; Raugei, G.; Ramponi, G.; Chiarugi, P. Intracellular reactive oxygen species activate Src tyrosine kinase during cell adhesion and anchorage-dependent cell growth. Mol. Cell Biol. 2005, 25, 6391-6403.
87. Inumaru, J.; Nagano, O.; Takahashi, E.; Ishimoto, T.; Nakamura, S.; Suzuki, Y.; Niwa, S.; Umezawa, K.; Tanihara, H.; Saya, H. Molecular mechanisms regulating dissociation of cell-cell junction of epithelial cells by oxidative stress. Genes Cells 2009, 14, 703-716.
88. Akhand, A.A.; Pu, M.; Senga, T.; Kato, M.; Suzuki, H.; Miyata, T.; Hamaguchi, M.; Nakashima, I. Nitric oxide controls src kinase activity through a sulfhydryl group modification-mediated Tyr-527-independent and Tyr-416-linked mechanism. J. Biol. Chem. 1999, 274, 25821-25826.
89. Rahman, M.A.; Senga, T.; Ito, S.; Hyodo, T.; Hasegawa, H.; Hamaguchi, M. S-nitrosylation at cysteine 498 of c-Src tyrosine kinase regulates nitric oxide-mediated cell invasion. J. Biol. Chem. 2009, 285, 3806-3814.
90. Onder, T.T.; Gupta, P.B.; Mani, S.A.; Yang, J.; Lander, E.S.; Weinberg, R.A. Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res. 2008, 68, 3645-3654.
91. Fidler, I.J. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat. Rev. Cancer 2003, 3, 453-458.
92. Sahai, E. Illuminating the metastatic process. Nat. Rev. Cancer 2007, 7, 737-749.
93. Chambers, A.F.; Groom, A.C.; MacDonald, I.C. Dissemination and growth of cancer cells in metastatic sites. Nat. Rev. Cancer 2002, 2, 563-572.
94. Weiss, L.; Nannmark, U.; Johansson, B.R.; Bagge, U. Lethal deformation of cancer cells in the microcirculation: a potential rate regulator of hematogenous metastasis. Int. J. Cancer 1992, 50, 103-107.
95. Al-Mehdi, A.B.; Tozawa, K.; Fisher, A.B.; Shientag, L.; Lee, A.; Muschel, R.J. Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis. Nat. Med. 2000, 6, 100-102.
96. Radomski, M.W.; Palmer, R.M.; Moncada, S. An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc. Natl. Acad. Sci. USA 1990, 87, 5193-5197.
97. Radomski, M.W.; Jenkins, D.C.; Holmes, L.; Moncada, S. Human colorectal adenocarcinoma cells: differential nitric oxide synthesis determines their ability to aggregate platelets. Cancer Res. 1991, 51, 6073-6078.
98. Rao, R.M.; Yang, L.; Garcia-Cardena, G.; Luscinskas, F.W. Endothelial-dependent mechanisms of leukocyte recruitment to the vascular wall. Circ. Res. 2007, 101, 234-247.
99. Ben-Baruch, A. Organ selectivity in metastasis: regulation by chemokines and their receptors. Clin. Exp. Metastasis 2008, 25, 345-356.
100. Gassmann, P.; Haier, J. The tumor cell-host organ interface in the early onset of metastatic organ colonisation. Clin. Exp. Metastasis 2008, 25, 171-181.
101. Koukoulis, G.K.; Patriarca, C.; Gould, V.E. Adhesion molecules and tumor metastasis. Hum. Pathol. 1998, 29, 889-892.
102. Borsig, L.; Wong, R.; Hynes, R.O.; Varki, N.M.; Varki, A. Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis. Proc. Natl. Acad. Sci. USA 2002, 99, 2193-2198.
103. Mehlen, P.; Puisieux, A. Metastasis: a question of life or death. Nat. Rev. Cancer 2006, 6, 449-458.
104. Orr, F.W.; Wang, H.H.; Lafrenie, R.M.; Scherbarth, S.; Nance, D.M. Interactions between cancer cells and the endothelium in metastasis. J. Pathol. 2000, 190, 310-329.
105. Estrela, J.M.; Ortega, A.; Obrador, E. Glutathione in cancer biology and therapy. Crit. Rev. Clin. Lab. Sci. 2006, 43, 143-181.
106. Fidler, I.J.; Nicolson, G.L. Organ selectivity for implantation survival and growth of B16 melanoma variant tumor lines. J. Natl. Cancer Inst. 1976, 57, 1199-1202.
107. Garofalo, A.; Chirivi, R.G.; Foglieni, C.; Pigott, R.; Mortarini, R.; Martin-Padura, I.; Anichini, A.; Gearing, A.J.; Sanchez-Madrid, F.; Dejana, E. et al. Involvement of the very late antigen 4 integrin on melanoma in interleukin 1-augmented experimental metastases. Cancer Res. 1995, 55, 414-419.
108. Klemke, M.; Weschenfelder, T.; Konstandin, M.H.; Samstag, Y. High affinity interaction of integrin alpha4beta1 (VLA-4) and vascular cell adhesion molecule 1 (VCAM-1) enhances migration of human melanoma cells across activated endothelial cell layers. J. Cell Physiol. 2007, 212, 368-374.
109. Marui, N.; Offermann, M.K.; Swerlick, R.; Kunsch, C.; Rosen, C.A.; Ahmad, M.; Alexander, R.W.; Medford, R.M. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J. Clin. Invest. 1993, 92, 1866-1874.
110. Bayon, L.G.; Izquierdo, M.A.; Sirovich, I.; van Rooijen, N.; Beelen, R.H.; Meijer, S. Role of Kupffer cells in arresting circulating tumor cells and controlling metastatic growth in the liver. Hepatology 1996, 23, 1224-1231.
111. Anasagasti, M.J.; Olaso, E.; Calvo, F.; Mendoza, L.; Martin, J.J.; Bidaurrazaga, J.; Vidal-Vanaclocha, F. Interleukin 1-dependent and -independent mouse melanoma metastases. J. Natl. Cancer Inst. 1997, 89, 645-651.
112. Mendoza, L.; Olaso, E.; Anasagasti, M.J.; Fuentes, A.M.; Vidal-Vanaclocha, F. Mannose receptor-mediated endothelial cell activation contributes to B16 melanoma cell adhesion and metastasis in liver. J. Cell Physiol. 1998, 174, 322-330.
113. Burdon, R.H. Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Radic. Biol. Med. 1995, 18, 775-794.
114. Blanchetot, C.; Boonstra, J. The ROS-NOX connection in cancer and angiogenesis. Crit. Rev. Eukaryot. Gene Expr. 2008, 18, 35-45.
115. Hancock, J.T. The role of redox mechanisms in cell signalling. Mol. Biotechnol. 2009, 43, 162-166.
116. Nishikawa, M. Reactive oxygen species in tumor metastasis. Cancer Lett. 2008, 266, 53-59.
117. Ishikawa, K.; Koshikawa, N.; Takenaga, K.; Nakada, K.; Hayashi, J. Reversible regulation of metastasis by ROS-generating mtDNA mutations. Mitochondrion 2008, 8, 339-344.
118. Lorusso, G.; Ruegg, C. The tumor microenvironment and its contribution to tumor evolution toward metastasis. Histochem. Cell Biol. 2008, 130, 1091-1103.
119. Fukumura, D.; Kashiwagi, S.; Jain, R.K. The role of nitric oxide in tumour progression. Nat. Rev. Cancer 2006, 6, 521-534.
120. Sonveaux, P.; Jordan, B.F.; Gallez, B.; Feron, O. Nitric oxide delivery to cancer: why and how? Eur. J. Cancer. 2009, 45, 1352-1369.
121. Jadeski, L.C.; Chakraborty, C.; Lala, P.K. Nitric oxide-mediated promotion of mammary tumour cell migration requires sequential activation of nitric oxide synthase, guanylate cyclase and mitogen-activated protein kinase. Int. J. Cancer 2003, 106, 496-504.
122. Wang, L.; Shi, G.G.; Yao, J.C.; Gong, W.; Wei, D.; Wu, T.T.; Ajani, J.A.; Huang, S.; Xie, K. Expression of endothelial nitric oxide synthase correlates with the angiogenic phenotype of and predicts poor prognosis in human gastric cancer. Gastric Cancer 2005, 8, 18-28.
123. Tu, Y.T.; Tao, J.; Liu, Y.Q.; Li, Y.; Huang, C.Z.; Zhang, X.B.; Lin, Y. Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in human malignant melanoma and their relation to angiogenesis. Clin. Exp. Dermatol. 2006, 31, 413-418.
124. Williams, E.L.; Djamgoz, M.B. Nitric oxide and metastatic cell behaviour. Bioessays 2005, 27, 1228-1238.
125. Ferreira, H.H.; Costa, R.A.; Jacheta, J.M.; Martins, A.R.; Medeiros, M.V.; Macedo-Soares, M.F.; De Luca, I.M.; Antunes, E.; De Nucci, G. Modulation of eosinophil migration from bone marrow to lungs of allergic rats by nitric oxide. Biochem. Pharmacol. 2004, 68, 631-639.
126. Clancy, R.; Leszczynska, J.; Amin, A.; Levartovsky, D.; Abramson, S.B. Nitric oxide stimulates ADP ribosylation of actin in association with the inhibition of actin polymerization in human neutrophils. J. Leukoc. Biol. 1995, 58, 196-202.
127. Dal Secco, D.; Paron, J.A.; de Oliveira, S.H.; Ferreira, S.H.; Silva, J.S.; Cunha Fde, Q. Neutrophil migration in inflammation: nitric oxide inhibits rolling, adhesion and induces apoptosis. Nitric Oxide 2003, 9, 153-164.
128. Ozturk, H.; Buyukbayram, H.; Ozdemir, E.; Ketani, A.; Gurel, A.; Onen, A.; Otcu, S. The effects of nitric oxide on the expression of cell adhesion molecules (ICAM-1, UEA-1, and tenascin) in rats with unilateral testicular torsion. J. Pediatr. Surg. 2003, 38, 1621-1627.
129. Radisavljevic, Z.; Avraham, H.; Avraham, S. Vascular endothelial growth factor up-regulates ICAM-1 expression via the phosphatidylinositol 3 OH-kinase/AKT/Nitric oxide pathway and modulates migration of brain microvascular endothelial cells. J. Biol. Chem. 2000, 275, 20770-20774.
130. Wang, H.H.; McIntosh, A.R.; Hasinoff, B.B.; Rector, E.S.; Ahmed, N.; Nance, D.M.; Orr, F.W. B16 melanoma cell arrest in the mouse liver induces nitric oxide release and sinusoidal cytotoxicity: a natural hepatic defense against metastasis. Cancer Res. 2000, 60, 5862-5869.
131. Hirst, D.G.; Robson, T. Nitrosative stress in cancer therapy. Front Biosci. 2007, 12, 3406-3418.
132. Lechner, M.; Lirk, P.; Rieder, J. Inducible nitric oxide synthase (iNOS) in tumor biology: the two sides of the same coin. Semin. Cancer Biol. 2005, 15, 277-289.
133. Carretero, J.; Obrador, E.; Esteve, J.M.; Ortega, A.; Pellicer, J.A.; Sempere, F.V.; Estrela, J.M. Tumoricidal activity of endothelial cells. Inhibition of endothelial nitric oxide production abrogates tumor cytotoxicity induced by hepatic sinusoidal endothelium in response to B16 melanoma adhesion in vitro. J. Biol. Chem. 2001, 276, 25775-25782.
134. Qiu, H.; Orr, F.W.; Jensen, D.; Wang, H.H.; McIntosh, A.R.; Hasinoff, B.B.; Nance, D.M.; Pylypas, S.; Qi, K.; Song, C.; Muschel, R.J.; Al-Mehdi, A.B. Arrest of B16 melanoma cells in the mouse pulmonary microcirculation induces endothelial nitric oxide synthase-dependent nitric oxide release that is cytotoxic to the tumor cells. Am. J. Pathol. 2003, 162, 403-412.
135. Jessup, J.M.; Battle, P.; Waller, H.; Edmiston, K.H.; Stolz, D.B.; Watkins, S.C.; Locker, J.; Skena, K. Reactive nitrogen and oxygen radicals formed during hepatic ischemia-reperfusion kill weakly metastatic colorectal cancer cells. Cancer Res. 1999, 59, 1825-1829.
136. Vidal-Vanaclocha, F. The prometastatic microenvironment of the liver. Cancer Microenviron. 2008, 1, 113-129.
137. Albertsson, P.A.; Nannmark, U.; Johansson, B.R. Melanoma cell destruction in the microvasculature of perfused hearts is reduced by pretreatment with vitamin E. Clin. Exp. Metastasis 1995, 13, 269-276.
138. Eskenazi, A.E.; Pinkas, J.; Whitin, J.C.; Arguello, F.; Cohen, H.J.; Frantz, C.N. Role of antioxidant enzymes in the induction of increased experimental metastasis by hydroxyurea. J. Natl. Cancer Inst. 1993, 85, 711-721.
139. Anasagasti, M.J.; Martin, J.J.; Mendoza, L.; Obrador, E.; Estrela, J.M.; McCuskey, R.S.; Vidal-Vanaclocha, F. Glutathione protects metastatic melanoma cells against oxidative stress in the murine hepatic microvasculature. Hepatology 1998, 27, 1249-1256.
140. Carretero, J.; Obrador, E.; Anasagasti, M.J.; Martin, J.J.; Vidal-Vanaclocha, F.; Estrela, J.M. Growth-associated changes in glutathione content correlate with liver metastatic activity of B16 melanoma cells. Clin. Exp. Metastasis 1999, 17, 567-574.
141. Obrador, E.; Carretero, J.; Ortega, A.; Medina, I.; Rodilla, V.; Pellicer, J.A.; Estrela, J.M. gamma-Glutamyl transpeptidase overexpression increases metastatic growth of B16 melanoma cells in the mouse liver. Hepatology 2002, 35, 74-81.
142. Ortega, A.L.; Carretero, J.; Obrador, E.; Gambini, J.; Asensi, M.; Rodilla, V.; Estrela, J.M. Tumor cytotoxicity by endothelial cells. Impairment of the mitochondrial system for glutathione uptake in mouse B16 melanoma cells that survive after in vitro interaction with the hepatic sinusoidal endothelium. J. Biol. Chem. 2003, 278, 13888-13897.
143. Meister, A. Glutathione deficiency produced by inhibition of its synthesis, and its reversal; applications in research and therapy. Pharmacol. Ther. 1991, 51, 155-194.
144. Kroemer, G.; Galluzzi, L.; Brenner, C. Mitochondrial membrane permeabilization in cell death. Physiol. Rev. 2007, 87, 99-163.
145. Vahrmeijer, A.L.; Hoetelmans, R.W.; Mulder, G.J.; Schutrups, J.; van Vlierberghe, R.L.; van de Velde, C.J.; van Dierendonck, J.H. Development of resistance to glutathione depletion-induced cell death in CC531 colon carcinoma cells: association with increased expression of bcl-2. Biochem. Pharmacol. 2000, 59, 1557-1562.
146. Baliga, B.C.; Kumar, S. Role of Bcl-2 family of proteins in malignancy. Hematol. Oncol. 2002, 20, 63-74.
147. Takaoka, A.; Adachi, M.; Okuda, H.; Sato, S.; Yawata, A.; Hinoda, Y.; Takayama, S.; Reed, J.C.; Imai, K. Anti-cell death activity promotes pulmonary metastasis of melanoma cells. Oncogene 1997, 14, 2971-2977.
148. Owen-Schaub, L.B.; van Golen, K.L.; Hill, L.L.; Price, J.E. Fas and Fas ligand interactions suppress melanoma lung metastasis. J. Exp. Med. 1998, 188, 1717-1723.
149. Lowe, S.W.; Lin, A.W. Apoptosis in cancer. Carcinogenesis 2000, 21, 485-495.
150. Wong, C.W.; Lee, A.; Shientag, L.; Yu, J.; Dong, Y.; Kao, G.; Al-Mehdi, A.B.; Bernhard, E.J.; Muschel, R.J. Apoptosis: an early event in metastatic inefficiency. Cancer Res. 2001, 61, 333-338.
151. Sartorius, U.A.; Krammer, P.H. Upregulation of Bcl-2 is involved in the mediation of chemotherapy resistance in human small cell lung cancer cell lines. Int. J. Cancer 2002, 97, 584-592.
152. Hickman, J.A. Apoptosis and tumourigenesis. Curr. Opin. Genet. Dev. 2002, 12, 67-72.
153. Zimmermann, K.C.; Bonzon, C.; Green, D.R. The machinery of programmed cell death. Pharmacol. Ther. 2001, 92, 57-70.
154. Patel, M.P.; Masood, A.; Patel, P.S.; Chanan-Khan, A.A. Targeting the Bcl-2. Curr. Opin. Oncol. 2009, 21, 516-523.
155. Ogretmen, B.; Safa, A.R. Down-regulation of apoptosis-related bcl-2 but not bcl-xL or bax proteins in multidrug-resistant MCF-7/Adr human breast cancer cells. Int. J. Cancer 1996, 67, 608-614.
156. Igney, F.H.; Krammer, P.H. Death and anti-death: tumour resistance to apoptosis. Nat. Rev. Cancer 2002, 2, 277-288.
157. Petrovic, A.S.; Young, R.L.; Hilgarth, B.; Ambros, P.; Korsmeyer, S.J.; Jaeger, U. The Ig heavy chain 3' end confers a posttranscriptional processing advantage to Bcl-2-IgH fusion RNA in t(14;18) lymphoma. Blood 1998, 91, 3952-3961.
158. Schiavone, N.; Rosini, P.; Quattrone, A.; Donnini, M.; Lapucci, A.; Citti, L.; Bevilacqua, A.; Nicolin, A.; Capaccioli, S. A conserved AU-rich element in the 3' untranslated region of bcl-2 mRNA is endowed with a destabilizing function that is involved in bcl-2 down-regulation during apoptosis. Faseb J. 2000, 14, 174-184.
159. Benlloch, M.; Ortega, A.; Ferrer, P.; Segarra, R.; Obrador, E.; Asensi, M.; Carretero, J.; Estrela, J.M. Acceleration of glutathione efflux and inhibition of gamma-glutamyltranspeptidase sensitize metastatic B16 melanoma cells to endothelium-induced cytotoxicity. J. Biol. Chem. 2005, 280, 6950-6959.
160. Yasuda, H. Solid tumor physiology and hypoxia-induced chemo/radio-resistance: novel strategy for cancer therapy: nitric oxide donor as a therapeutic enhancer. Nitric Oxide 2008, 19, 205-216.
161. Dadras, S.S.; Lange-Asschenfeldt, B.; Velasco, P.; Nguyen, L.; Vora, A.; Muzikansky, A.; Jahnke, K.; Hauschild, A.; Hirakawa, S.; Mihm, M.C.; Detmar, M. Tumor lymphangiogenesis predicts melanoma metastasis to sentinel lymph nodes. Mod. Pathol. 2005, 18, 1232-1242.
162. Ono, M. Molecular links between tumor angiogenesis and inflammation: inflammatory stimuli of macrophages and cancer cells as targets for therapeutic strategy. Cancer. Sci. 2008, 99, 1501-1506.
163. Gupta, K.; Zhang, J. Angiogenesis: a curse or cure? Postgrad. Med. J. 2005, 81, 236-242.
164. Holmgren, L.; O'Reilly, M.S.; Folkman, J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat. Med. 1995, 1, 149-153.
165. Bertolini, F. Chemotherapy and the tumor microenvironment: the contribution of circulating endothelial cells. Cancer Metastasis Rev. 2008, 27, 95-101.
166. Watari, K.; Nakao, S.; Fotovati, A.; Basaki, Y.; Hosoi, F.; Bereczky, B.; Higuchi, R.; Miyamoto, T.; Kuwano, M.; Ono, M. Role of macrophages in inflammatory lymphangiogenesis: Enhanced production of vascular endothelial growth factor C and D through NF-kappaB activation. Biochem. Biophys. Res. Commun 2008, 377, 826-831.
167. Fang, J.; Seki, T.; Maeda, H. Therapeutic strategies by modulating oxygen stress in cancer and inflammation. Adv. Drug Deliv. Rev. 2009, 61, 290-302.
168. Moreno-Sanchez, R.; Rodriguez-Enriquez, S.; Marin-Hernandez, A.; Saavedra, E. Energy metabolism in tumor cells. Febs J. 2007, 274, 1393-1418.
169. Jackson, J.R.; Seed, M.P.; Kircher, C.H.; Willoughby, D.A.; Winkler, J.D. The codependence of angiogenesis and chronic inflammation. Faseb J. 1997, 11, 457-465.
170. Taranova, A.G.; Maldonado, D. 3rd; Vachon, C.M.; Jacobsen, E.A.; Abdala-Valencia, H.; McGarry, M.P.; Ochkur, S.I.; Protheroe, C.A.; Doyle, A.; Grant, C.S.; Cook-Mills, J.; Birnbaumer, L.; Lee, N.A.; Lee, J.J. Allergic pulmonary inflammation promotes the recruitment of circulating tumor cells to the lung. Cancer Res. 2008, 68, 8582-8589.
171. Rice, G.E.; Gimbrone, M.A. Jr.; Bevilacqua, M.P. Tumor cell-endothelial interactions. Increased adhesion of human melanoma cells to activated vascular endothelium. Am. J. Pathol. 1988, 133, 204-210.
172. Federico, A.; Morgillo, F.; Tuccillo, C.; Ciardiello, F.; Loguercio, C. Chronic inflammation and oxidative stress in human carcinogenesis. Int. J. Cancer 2007, 121, 2381-2386.
173. Campisi, J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 2005, 120, 513-522.
174. Fidler, I.J. Metastasis: guantitative analysis of distribution and fate of tumor embolilabeled with 125 I-5-iodo-2'-deoxyuridine. J. Natl. Cancer Inst. 1970, 45, 773-782.
175. Barbera-Guillem, E.; Smith, I.; Weiss, L. Cancer-cell traffic in the liver. II. Arrest, transit and death of B16F10 and M5076 cells in the sinusoids. Int. J. Cancer 1993, 53, 298-301.
176. Weiss, L. Biomechanical interactions of cancer cells with the microvasculature during hematogenous metastasis. Cancer Metastasis Rev. 1992, 11, 227-235.
177. Bouwens, L.; Jacobs, R.; Remels, L.; Wisse, E. Natural cytotoxicity of rat hepatic natural killer cells and macrophages against a syngeneic colon adenocarcinoma. Cancer Immunol. Immunother. 1988, 27, 137-141.
178. Bockhorn, M.; Jain, R.K.; Munn, L.L. Active versus passive mechanisms in metastasis: do cancer cells crawl into vessels, or are they pushed? Lancet Oncol. 2007, 8, 444-448.
179. Weiss, L. Metastatic inefficiency. Adv. Cancer Res. 1990, 54, 159-211.
180. Trumpp, A.; Wiestler, O.D. Mechanisms of Disease: cancer stem cells--targeting the evil twin. Nat. Clin. Pract. Oncol. 2008, 5, 337-347.
181. Xie, K.; Huang, S. Regulation of cancer metastasis by stress pathways. Clin. Exp. Metastasis 2003, 20, 31-43.
182. Fratelli, M.; Goodwin, L.O.; Orom, U.A.; Lombardi, S.; Tonelli, R.; Mengozzi, M.; Ghezzi, P. Gene expression profiling reveals a signaling role of glutathione in redox regulation. Proc. Natl. Acad. Sci. USA 2005, 102, 13998-14003.
183. Zhou, Q.; Liu, L.Z.; Fu, B.; Hu, X.; Shi, X.; Fang, J.; Jiang, B.H. Reactive oxygen species regulate insulin-induced VEGF and HIF-1alpha expression through the activation of p70S6K1 in human prostate cancer cells. Carcinogenesis 2007, 28, 28-37.
184. Wu, W.S. The signaling mechanism of ROS in tumor progression. Cancer Metastasis Rev. 2006, 25, 695-705.
185. Kroncke, K.D. Mechanisms and biological consequences of nitrosative stress. Biol. Chem. 2003, 384, 1341.
186. Mena, S.; Benlloch, M.; Ortega, A.; Carretero, J.; Obrador, E.; Asensi, M.; Petschen, I.; Brown, B.D.; Estrela, J.M. Bcl-2 and glutathione depletion sensitizes B16 melanoma to combination therapy and eliminates metastatic disease. Clin. Cancer Res. 2007, 13, 2658-2666.
187. Ferrer, P.; Asensi, M.; Priego, S.; Benlloch, M.; Mena, S.; Ortega, A.; Obrador, E.; Esteve, J.M.; Estrela, J.M. Nitric oxide mediates natural polyphenol-induced Bcl-2 down-regulation and activation of cell death in metastatic B16 melanoma. J. Biol. Chem. 2007, 282, 2880-2890.
188. Chanvorachote, P.; Nimmannit, U.; Stehlik, C.; Wang, L.; Jiang, B.H.; Ongpipatanakul, B.; Rojanasakul, Y. Nitric oxide regulates cell sensitivity to cisplatin-induced apoptosis through S-nitrosylation and inhibition of Bcl-2 ubiquitination. Cancer Res. 2006, 66, 6353-6360.
189. Azad, N.; Vallyathan, V.; Wang, L.; Tantishaiyakul, V.; Stehlik, C.; Leonard, S.S.; Rojanasakul, Y. S-nitrosylation of Bcl-2 inhibits its ubiquitin-proteasomal degradation. A novel antiapoptotic mechanism that suppresses apoptosis. J. Biol. Chem. 2006, 281, 34124-34134.
190. Wang, J.; Yi, J. Cancer cell killing via ROS: to increase or decrease, that is the question. Cancer Biol. Ther. 2008, 7, 1875-1884.
191. Ramsey, M.R.; Sharpless, N.E. ROS as a tumour suppressor? Nat. Cell Biol. 2006, 8, 1213-1215.
192. D'Autreaux, B.; Toledano, M.B. ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat. Rev. Mol. Cell Biol. 2007, 8, 813-824.
193. Ushio-Fukai, M.; Nakamura, Y. Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy. Cancer Lett. 2008, 266, 37-52.
194. Clerkin, J.S.; Naughton, R.; Quiney, C.; Cotter, T.G. Mechanisms of ROS modulated cell survival during carcinogenesis. Cancer Lett. 2008, 266, 30-36.
195. Wu, X.J.; Hua, X. Targeting ROS: selective killing of cancer cells by a cruciferous vegetable derived pro-oxidant compound. Cancer Biol. Ther. 2007, 6, 646-647.
196. Giles, G.I. The redox regulation of thiol dependent signaling pathways in cancer. Curr. Pharm. Des. 2006, 12, 4427-4443.
197. Koeberle, A.; Northoff, H.; Werz, O. Curcumin blocks prostaglandin E2 biosynthesis through direct inhibition of the microsomal prostaglandin E2 synthase-1. Mol. Cancer Ther. 2009, 8, 2348-2355.
198. Purkayastha, S.; Berliner, A.; Fernando, S.S.; Ranasinghe, B.; Ray, I.; Tariq, H.; Banerjee, P. Curcumin blocks brain tumor formation. Brain Res. 2009, 1266, 130-138.
199. Malhotra, A.; Nair, P.; Dhawan, D.K. Modulatory effects of curcumin and resveratrol on lung carcinogenesis in mice. Phytother. Res. 2009, DOI: 10.1002/ptr.3087.
200. Bishayee, A.; Politis, T.; Darvesh, A.S. Resveratrol in the chemoprevention and treatment of hepatocellular carcinoma. Cancer Treat. Rev. 2009, 36, 43-45.
201. Sengottuvelan, M.; Deeptha, K.; Nalini, N. Resveratrol ameliorates DNA damage, prooxidant and antioxidant imbalance in 1,2-dimethylhydrazine induced rat colon carcinogenesis. Chem. Biol. Interact. 2009, 181, 193-201.
202. Yang, Z.; Yang, S.; Misner, B.J.; Chiu, R.; Liu, F.; Meyskens, F.L. Jr. Nitric oxide initiates progression of human melanoma via a feedback loop mediated by apurinic/apyrimidinic endonuclease-1/redox factor-1, which is inhibited by resveratrol. Mol. Cancer Ther. 2008, 7, 3751-3760.
203. Paul, S.; Decastro, A.; Lee, H.J.; Smolarek, A.K.; So, J.Y.; Simi, B.; Wang, C.X.; Zhou, R.; Rimando, A.M.; Suh, N. Dietary intake of pterostilbene, a constituent of blueberries, inhibits the {beta}-catenin/p65 downstream signaling pathway and colon carcinogenesis in rats. Carcinogenesis. 2010, in press.
204. Cichocki, M.; Paluszczak, J.; Szaefer, H.; Piechowiak, A.; Rimando, A.M.; Baer-Dubowska, W. Pterostilbene is equally potent as resveratrol in inhibiting 12-O-tetradecanoylphorbol-13-acetate activated NFkappaB, AP-1, COX-2, and iNOS in mouse epidermis. Mol. Nutr. Food Res. 2008, 52 (Suppl. 1), S62-S70.
205. Fu, H.; He, J.; Mei, F.; Zhang, Q.; Hara, Y.; Ryota, S.; Lubet, R.A.; Chen, R.; Chen, D.R.; You, M. Lung cancer inhibitory effect of epigallocatechin-3-gallate is dependent on its presence in a complex mixture (polyphenon E). Cancer Prev. Res. (Phila Pa) 2009, 2, 531-537.
206. Butt, M.S.; Sultan, M.T. Green tea: nature's defense against malignancies. Crit. Rev. Food Sci. Nutr. 2009, 49, 463-473.
207. Shan, B.E.; Wang, M.X.; Li, R.Q. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway. Cancer Invest. 2009, 27, 604-612.
208. Murakami, A.; Ashida, H.; Terao, J. Multitargeted cancer prevention by quercetin. Cancer Lett. 2008, 269, 315-325.
209. Ng, Q.S.; Goh, V.; Milner, J.; Stratford, M.R.; Folkes, L.K.; Tozer, G.M.; Saunders, M.I.; Hoskin, P.J. Effect of nitric-oxide synthesis on tumour blood volume and vascular activity: a phase I study. Lancet Oncol. 2007, 8, 111-118.
210. Ozben, T. Oxidative stress and apoptosis: impact on cancer therapy. J. Pharm. Sci. 2007, 96, 2181-2196.
211. Renschler, M.F. The emerging role of reactive oxygen species in cancer therapy. Eur. J. Cancer 2004, 40, 1934-1940.
212. Brune, B.; Zhou, J. Nitric oxide and superoxide: interference with hypoxic signaling. Cardiovasc. Res. 2007, 75, 275-282.
213. Priego, S.; Feddi, F.; Ferrer, P.; Mena, S.; Benlloch, M.; Ortega, A.; Carretero, J.; Obrador, E.; Asensi, M.; Estrela, J.M. Natural polyphenols facilitate elimination of HT-29 colorectal cancer xenografts by chemoradiotherapy: a Bcl-2- and superoxide dismutase 2-dependent mechanism. Mol. Cancer Ther. 2008, 7, 3330-3342.
214. Roy, P.; Nigam, N.; George, J.; Srivastava, S.; Shukla, Y. Induction of apoptosis by tea polyphenols mediated through mitochondrial cell death pathway in mouse skin tumors. Cancer Biol. Ther. 2009, 8, 1281-1287.
215. Halder, B.; Bhattacharya, U.; Mukhopadhyay, S.; Giri, A.K. Molecular mechanism of black tea polyphenols induced apoptosis in human skin cancer cells: involvement of Bax translocation and mitochondria mediated death cascade. Carcinogenesis 2008, 29, 129-138.
216. Schneider, J.G.; Alosi, J.A.; McDonald, D.E.; McFadden, D.W. Pterostilbene Inhibits Lung Cancer Through Induction of Apoptosis. J. Surg. Res. 2009, doi:10.1016/j.jss.2009.06.027.
217. Alosi, J.A.; McDonald, D.E.; Schneider, J.S.; Privette, A.R.; McFadden, D.W. Pterostilbene Inhibits Breast Cancer In Vitro Through Mitochondrial Depolarization and Induction of Caspase-Dependent Apoptosis. J. Surg. Res. 2009, doi:10.1016/j.jss.2009.07.027.
218. Yu, Y.; Kanwar, S.S.; Patel, B.B.; Nautiyal, J.; Sarkar, F.H.; Majumdar, A.P. Elimination of Colon Cancer Stem-Like Cells by the Combination of Curcumin and FOLFOX. Transl. Oncol. 2009, 2, 321-328.
219. Yoon, M.J.; Kim, E.H.; Lim, J.H.; Kwon, T.K.; Choi, K.S. Superoxide anion and proteasomal dysfunction contribute to curcumin-induced paraptosis of malignant breast cancer cells. Free Radic. Biol. Med. 2009, 48, 713-726.